Journey Medical (DERM) Non-Current Debt (2020 - 2025)
Historic Non-Current Debt for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $19.5 million.
- Journey Medical's Non-Current Debt fell 126.86% to $19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.5 million, marking a year-over-year decrease of 126.86%. This contributed to the annual value of $24.9 million for FY2024, which is 7014.77% up from last year.
- Latest data reveals that Journey Medical reported Non-Current Debt of $19.5 million as of Q3 2025, which was down 126.86% from $21.4 million recorded in Q2 2025.
- Journey Medical's Non-Current Debt's 5-year high stood at $24.9 million during Q4 2024, with a 5-year trough of $9.9 million in Q1 2023.
- In the last 5 years, Journey Medical's Non-Current Debt had a median value of $19.6 million in 2024 and averaged $18.0 million.
- Per our database at Business Quant, Journey Medical's Non-Current Debt tumbled by 3280.77% in 2023 and then surged by 7014.77% in 2024.
- Quarter analysis of 5 years shows Journey Medical's Non-Current Debt stood at $15.0 million in 2021, then skyrocketed by 32.42% to $19.8 million in 2022, then dropped by 26.25% to $14.6 million in 2023, then surged by 70.15% to $24.9 million in 2024, then dropped by 21.48% to $19.5 million in 2025.
- Its last three reported values are $19.5 million in Q3 2025, $21.4 million for Q2 2025, and $23.1 million during Q1 2025.